<div id="readability-page-1"><article><div><p>,  /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3 at 7:35 a.m. ET.</p><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2460831/Grail_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="400" height="76" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2460831/Grail_Logo.jpg"/></p><p>Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.</p><p><b>About GRAIL<br/></b>GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.</p><p>For more information, visit grail.com.</p><p>SOURCE GRAIL, Inc.</p></div></article></div>

GRAL

<p>GRAIL, Inc. (Nasdaq: GRAL) will present at the 2026 Jefferies Global Healthcare Conference on June 3 at 7:35 a.m. ET. The event will be accessible via live and replay webcasts on GRAIL's investor relations website. GRAIL focuses on early cancer detection using advanced technologies.</p>

StockTitan

GRAIL

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

Ark Genomic Revolution ETF

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

iShares US Medical Devices

iShares Genomics Immunology and Healthcare ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares US Healthcare Providers

GRAIL to Present at the 2026 Jefferies Global Healthcare Conference | GRAL Stock News